0001225208-24-002096.txt : 20240214
0001225208-24-002096.hdr.sgml : 20240214
20240214183613
ACCESSION NUMBER: 0001225208-24-002096
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240212
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Decker Robert J
CENTRAL INDEX KEY: 0001798703
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 24641265
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0508
4
2024-02-12
0000200406
JOHNSON & JOHNSON
JNJ
0001798703
Decker Robert J
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
VP Corporate Controller
0
Common Stock
2024-02-12
4
M
0
1637.0000
0.0000
A
18994.0000
D
Common Stock
2024-02-12
4
M
0
275.0000
0.0000
A
19269.0000
D
Common Stock
2024-02-12
4
F
0
523.0000
157.4000
D
18746.0000
D
Common Stock
597.0000
I
By 401k
Common Stock
134.0000
I
By ESOP
Performance Share Units
2024-02-12
4
M
0
1637.0000
0.0000
D
2024-02-08
Common Stock
1637.0000
0.0000
D
Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024.
Shares earned due to performance factor of 116.8% upon certification of performance results by the Board.
Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
/s/ Raavi K. Deol, as attorney-in-fact for Robert J. Decker
2024-02-14